NewAmsterdam Pharma Company N.V.
(NAMS - NASDAQ)
25,40 USD
📋 Profilo Aziendale

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease.

|